EVGEN PHARMA
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
EVGEN PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2007-01-01
Address:
Wilmslow, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evgen.com
Total Employee:
1+
Status:
Active
Contact:
+44 151 705 3532
Email Addresses:
[email protected]
Total Funding:
16.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Acceleris Capital
Acceleris Capital investment in Venture Round - Evgen Pharma
Seneca Partners
Seneca Partners investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Venture Round - Evgen Pharma
Sarum Partners
Sarum Partners investment in Venture Round - Evgen Pharma
Enterprise Ventures
Enterprise Ventures investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Series A - Evgen Pharma
Rising Stars Growth Fund
Rising Stars Growth Fund investment in Series A - Evgen Pharma
Imprimatur Capital
Imprimatur Capital investment in Seed Round - Evgen Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-22 | Evgen Pharma names chief business officer |
Official Site Inspections
http://www.evgen.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: pl1.jpcinet.co.uk
- IP address: 212.113.198.195
- Location: Crawley United Kingdom
- Latitude: 51.1149
- Longitude: -0.1841
- Timezone: Europe/London
- Postal: RH11
